reference/9213668

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9213668

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1270
issn	0149-5992 1935-5548
issueIdentifier	6
pageRange	1265-1270
publicationName	Diabetes Care
startingPage	1265
bibliographicCitation	Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N, Hale PM; Repaglinide Versus Nateglinide Comparison Study Group. Repaglinide versus nateglinide monotherapy: a randomized, multicenter study. Diabetes Care. 2004 Jun;27(6):1265–70. doi: 10.2337/diacare.27.6.1265. PMID: 15161773.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53f63dcf99a5accee617c259da7e39df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1bb65ddaaf7fb707a8bed09187f1c25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74b2219dedc94f4d7dc52a567589d942 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2cca461d57aab623061a8bb680b74da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd4c62835e17c20231515549aff392e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8768e2972f1dcf4f7d921e93522bfe72 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4741-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e154c2ec730538bcde7f82e39cd259b
date	2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.2337/diacare.27.6.1265 https://pubmed.ncbi.nlm.nih.gov/15161773
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3416 https://portal.issn.org/resource/ISSN/0149-5992 https://portal.issn.org/resource/ISSN/1935-5548
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Repaglinide versus nateglinide monotherapy: a randomized, multicenter study
discusses	http://id.nlm.nih.gov/mesh/M0353981 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0010114 http://id.nlm.nih.gov/mesh/M0196126 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0005469 http://id.nlm.nih.gov/mesh/M0003327
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003510Q000627 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D010649Q000627 http://id.nlm.nih.gov/mesh/D002219Q000627 http://id.nlm.nih.gov/mesh/D010880Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000178 http://id.nlm.nih.gov/mesh/D003924Q000534 http://id.nlm.nih.gov/mesh/D003927 http://id.nlm.nih.gov/mesh/D015444 http://id.nlm.nih.gov/mesh/D000077715 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006442Q000032 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015992
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65981 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55029e08d2afcf59a719caf55a149021 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa5fc799a3f3c6277beeb3473c262800 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132283 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_33045cbeee04a3e57791bf0177468bcf

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127816805 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433

Total number of triples: 71.